Enigma Diagnostics
The UK firm has purchased the assets for Enigma Diagnostics and anticipates it will soon receive clearance to market its first test for TB in China.
Enigma Selling Point-of-Care Dx Tech
The UK-based firm is selling technology underlying its point-of-care molecular diagnostics platform, the Enigma MiniLab.
Researchers Evaluate Enigma's Multiplex POC Flu/RSV Assay as Firm Touts Syndromic Capabilities
Premium
The Enigma MiniLab runs single-tube multiplex panels at the point of care, with a lower price point than other commercially available syndromic panel platforms.
Enigma Dx Inks Joint Venture, $50M Subscription Agreements
NEW YORK (GenomeWeb) – Enigma Diagnostics and Beijing Leadman Biochemistry today announced a joint venture agreement aimed at bringing Enigma's point-of-care molecular diagnostic system to China.
NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.
Jan 16, 2014
Aug 1, 2013
Aug 10, 2011
Aug 10, 2011
Enigma, GSK Sign Infectious Disease Testing Pact
Jul 19, 2011
Apr 14, 2011
Apr 11, 2011
Enigma Dx Filing Influenza A/B Assay in 2012
Jan 11, 2011
Tecan Licenses Molecular Dx IP from Enigma
Mar 4, 2010
People in the News: Mar 4, 2010
Premium
Dec 9, 2009
Pairings: Dec 9, 2009
Premium
Nov 25, 2009
Enigma Diagnostics Opens US Office
Jul 24, 2009